ConductScience.org, home

Paper33859752

Turning cold tumors into hot tumors by improving T-cell infiltration.

Liu YT and 1 other. Theranostics, 2021. Cited by 680 papers, by iCite.

Cite this record

ConductScience Library. Turning cold tumors into hot tumors by improving T-cell infiltration. Papers, record 33859752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Turning cold tumors into hot tumors by improving T-cell infiltration.
PubMed
Journal
Theranostics
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
680
iCite
Relative citation ratio, by iCite
36.7
iCite
Revised in PubMed
2022-02-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YTYuan-Tong
2Sun ZJZhi-Jun

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
T-LymphocytesMajor topic
Animals
Antigens, Neoplasm
Humans
Immunotherapy
Nanomedicine

Source PubMed

Download CSV of topics

References176

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132699309Clinical development and potential of photothermal and photodynamic therapies for cancer.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32699309PubMed
228187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
326411680Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner.Cell Rep2015https://conductscience.org/library/papers/26411680PubMed
428486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
529443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
632117585PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models.Oncoimmunology2020https://conductscience.org/library/papers/32117585PubMed
722592077The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.J Exp Clin Cancer Res2012https://conductscience.org/library/papers/22592077PubMed
828231431Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.ACS Nano2017https://conductscience.org/library/papers/28231431PubMed
932760014Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32760014PubMed
1030914826Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/30914826PubMed
1131548600The emerging role of epigenetic therapeutics in immuno-oncology.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/31548600PubMed
1229431745DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation.Nat Med2018https://conductscience.org/library/papers/29431745PubMed
1326321679Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.Cell2015https://conductscience.org/library/papers/26321679PubMed
1422224781Regulatory T cells: mechanisms of differentiation and function.Annu Rev Immunol2012https://conductscience.org/library/papers/22224781PubMed
1530849371VEGF in Signaling and Disease: Beyond Discovery and Development.Cell2019https://conductscience.org/library/papers/30849371PubMed
1627718784Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med2016https://conductscience.org/library/papers/27718784PubMed
1726014293Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.J Clin Oncol2015https://conductscience.org/library/papers/26014293PubMed
1831690840The gasdermins, a protein family executing cell death and inflammation.Nat Rev Immunol2020https://conductscience.org/library/papers/31690840PubMed
1929025772Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.Cancer Discov2017https://conductscience.org/library/papers/29025772PubMed
2029120755Migrating into the Tumor: a Roadmap for T Cells.Trends Cancer2017https://conductscience.org/library/papers/29120755PubMed

See all 176 referencesDownload CSV of references

Cited by509

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 680 citations.

PMIDTitleJournalYearIn PapersSource
42979366Biomimetic tumor microenvironment-responsive prodrug amplifies photoimmunotherapy via TLR2 agonist.Acta Pharm Sin B2026https://conductscience.org/library/papers/42979366PubMed
42973806Ultrasound-responsive nanoplatforms for cancer immunotherapy: engineering spatiotemporal immune activation in the tumor microenvironment.Front Immunol2026https://conductscience.org/library/papers/42973806PubMed
42920907Molecular and immune-mediated resistance to antibody-drug conjugates in breast cancer.Front Immunol2026https://conductscience.org/library/papers/42920907PubMed
42909908Targeting NOTCH-immune crosstalk in gliomas: from mechanisms to therapeutics.Front Oncol2026https://conductscience.org/library/papers/42909908PubMed
42877086Biomaterial-driven remove-remodel-repair (3R) strategy for full-cycle gastric cancer management: bibliometric mapping, preclinical evidence, and a translational roadmap.Nanoscale Adv2026https://conductscience.org/library/papers/42877086PubMed
42876375Clinicopathological Features of DLL3 Expression and T-Cell Infiltration in LCNEC: Insights From Pathology and Clinical Response to Tarlatamab.Thorac Cancer2026https://conductscience.org/library/papers/42876375PubMed
42795401The Relationship Between Immunogenic Cell Death and Cellular Senescence in Cancer Immunotherapy.Life (Basel)2026https://conductscience.org/library/papers/42795401PubMed
42753002Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives.J Immunol Res2026https://conductscience.org/library/papers/42753002PubMed
42699686Targeted PD-L1 degradation with an injectable hydrogel reverses chemotherapy-induced compensatory immunosuppression and enhances antitumor immunity.Mater Today Bio2026https://conductscience.org/library/papers/42699686PubMed
42695424Dendritic cell‑based vaccines for colorectal cancer: Mechanisms, clinical progress and future directions (Review).Int J Oncol2026https://conductscience.org/library/papers/42695424PubMed
42614350A tissue microenvironment analogous to certain tumor microenvironments facilitates HIV persistence.Front Immunol2026https://conductscience.org/library/papers/42614350PubMed
42608511Cold and hot tumors: immunological determinants, cancer-immunity cycle dysregulation, and nanotechnology-driven therapeutic approaches.Mol Biomed2026https://conductscience.org/library/papers/42608511PubMed
42597511Development and Validation of an HPLC-MS/MS Method for Determining BMS-1166, GB-1107, and Enzalutamide in Rat Plasma and Its Application to Pharmacokinetic Studies.Drug Des Devel Ther2026https://conductscience.org/library/papers/42597511PubMed
42596654cGAS-STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy.Cancer Biol Med2026https://conductscience.org/library/papers/42596654PubMed
42564263Tumor organoid-immune cell co-culture systems for precision oncology.Front Cell Dev Biol2026https://conductscience.org/library/papers/42564263PubMed
42536164NKR+CD8+ T cells and iNKT cells protect mice from AOM/DSS-induced colorectal cancer under conditions of IFNγ-mediated hyperinflammation.Inflamm Res2026https://conductscience.org/library/papers/42536164PubMed
42521766Symmetric cancer spheroid-fibroblast organization revealed in 3D by high-throughput microscopy.Commun Biol2026https://conductscience.org/library/papers/42521766PubMed
42512390Prognostic Value of Morphological Characteristics and Immune Microenvironment in High-Grade Serous Cancer (HGSC).Cancers (Basel)2026https://conductscience.org/library/papers/42512390PubMed
42467537PANoptosis and Immune Remodeling in the Tumor Microenvironment.FASEB J2026https://conductscience.org/library/papers/42467537PubMed
42459668Immune checkpoint inhibitors in dMMR-MSI-H colorectal cancer: rationale, progress and prospects.Front Immunol2026https://conductscience.org/library/papers/42459668PubMed

See all 509 cited byDownload CSV of cited by

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACP355PubTator's text mininghttps://conductscience.org/library/genes/55NCBI Gene
ANGPT2285PubTator's text mininghttps://conductscience.org/library/genes/285NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BATF355509PubTator's text mininghttps://conductscience.org/library/genes/55509NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
CCL196363PubTator's text mininghttps://conductscience.org/library/genes/6363NCBI Gene
CCL46351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CX3CL16376PubTator's text mininghttps://conductscience.org/library/genes/6376NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL94283PubTator's text mininghttps://conductscience.org/library/genes/4283NCBI Gene
DKK122943PubTator's text mininghttps://conductscience.org/library/genes/22943NCBI Gene
DKK227123PubTator's text mininghttps://conductscience.org/library/genes/27123NCBI Gene
FLT3LG2323PubTator's text mininghttps://conductscience.org/library/genes/2323NCBI Gene

See all 34 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33859752

GET https://conductscience.org/api/papers/v1/33859752/references?page=2